Madrigal Pharmaceuticals Inc (MDGL)
331.32
+11.74
(+3.67%)
USD |
NASDAQ |
Nov 04, 16:00
333.99
+2.67
(+0.81%)
Pre-Market: 08:32
Madrigal Pharmaceuticals Price to Book Value: 9.298 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 9.298 |
| November 01, 2024 | 8.969 |
| October 31, 2024 | 7.278 |
| October 30, 2024 | 6.060 |
| October 29, 2024 | 6.112 |
| October 28, 2024 | 6.09 |
| October 25, 2024 | 5.911 |
| October 24, 2024 | 5.696 |
| October 23, 2024 | 5.681 |
| October 22, 2024 | 5.713 |
| October 21, 2024 | 5.861 |
| October 18, 2024 | 6.017 |
| October 17, 2024 | 5.906 |
| October 16, 2024 | 6.050 |
| October 15, 2024 | 6.066 |
| October 14, 2024 | 6.045 |
| October 11, 2024 | 6.009 |
| October 10, 2024 | 5.909 |
| October 09, 2024 | 5.917 |
| October 08, 2024 | 6.082 |
| October 07, 2024 | 6.028 |
| October 04, 2024 | 5.848 |
| October 03, 2024 | 5.796 |
| October 02, 2024 | 5.869 |
| October 01, 2024 | 5.874 |
| Date | Value |
|---|---|
| September 30, 2024 | 5.955 |
| September 27, 2024 | 5.381 |
| September 26, 2024 | 5.418 |
| September 25, 2024 | 5.477 |
| September 24, 2024 | 5.651 |
| September 23, 2024 | 5.718 |
| September 20, 2024 | 5.915 |
| September 19, 2024 | 6.137 |
| September 18, 2024 | 5.906 |
| September 17, 2024 | 5.912 |
| September 16, 2024 | 5.912 |
| September 13, 2024 | 6.125 |
| September 12, 2024 | 5.947 |
| September 11, 2024 | 5.902 |
| September 10, 2024 | 5.970 |
| September 09, 2024 | 6.046 |
| September 06, 2024 | 6.178 |
| September 05, 2024 | 6.232 |
| September 04, 2024 | 6.215 |
| September 03, 2024 | 5.988 |
| August 30, 2024 | 6.260 |
| August 29, 2024 | 6.301 |
| August 28, 2024 | 6.353 |
| August 27, 2024 | 6.455 |
| August 26, 2024 | 6.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.407
Minimum
Apr 03 2020
495.87
Maximum
Dec 29 2022
25.58
Average
7.296
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals Inc | 4.694 |
| Sarepta Therapeutics Inc | 10.90 |
| ADMA Biologics Inc | 23.66 |
| Intra-Cellular Therapies Inc | 7.980 |
| Entrada Therapeutics Inc | 1.536 |
Price to Book Value Related Metrics
| PEG Ratio | -0.4316 |
| Price | 331.32 |
| Earnings Yield | -7.58% |
| Market Cap | 7.226B |
| PEGY Ratio | -0.4316 |